Boston, MA 04\/09\/2014 (wallstreetpr) –\u00a0The globally leading Pharmaceutical Company called Questcor Pharmaceuticals Inc (NASDAQ:QCOR) <\/b>is now under the scanner <\/b>of <\/b>Faruqi and Faruqi. As a Questcor investor alert, Faruqi and Faruqi, LLP has announced investigation of QCOR (Questcor Pharmaceuticals, Inc.) over the sale of the company to Mallinckrodt plc. Faruqi and Faruqi, LLP, which is one of the leading national securities having its headquarter in New York is in charge of this investigation.<\/p>\n
The company entered into a definitive agreement by which Mallinckrodt would acquire Questcor Pharmaceuticals Inc (NASDAQ:QCOR). The investigation would include the board of directors of the company. Juan E. Monteverde, who is partner of Faruqi and Faruqi, LLP, is investigating this matter in connection to the acclaimed sales to Mallinckrodt plc for a heavy amount of approx $5.2 billion. In that case, the company\u2019s stakeholders would be receiving $30.00 cash and about 0.897 Mallinckrodt shares per each share they own currently.<\/p>\n
Investigation backdrop <\/b><\/p>\n
The investigation would be taking place following the stories of the board of directors of the company, breaching their fiduciary duties and thus failing to conduct a sales process that ought to have been a fair one. Faruqi and Faruqi, LLP, has focused on giving services, securities, antitrust and shareholder.<\/p>\n
The investigation would happen following the merging of both the companies. As a matter of fact, the shareholders of Mallinckrodt will approximately own 50.5%, and all the former shareholders who are part of Questcor would own approximately 49.5% all in all. As on April 4, 2014, the closing price of both the companies represents approximately a premium of 27% per share over the stock price of Questcor Pharmaceuticals Inc (NASDAQ:QCOR).<\/p>\n
Reportedly, with the merge of both the companies in place, Mallinckrodt will be diversified with the significant increase in the sales, cash flows and transactions, the revenues and profit. This in turn is expected to deliver a huge growth and value for the shareholders associated with both the companies. As the investigation is placed, the outcomes would be very significant for both the companies and their shareholders.<\/p>\n","protected":false},"excerpt":{"rendered":"
Boston, MA 04\/09\/2014 (wallstreetpr) –\u00a0The globally leading Pharmaceutical Company called Questcor Pharmaceuticals Inc (NASDAQ:QCOR) is now under the scanner of Faruqi and Faruqi. As a […]<\/p>\n","protected":false},"author":2,"featured_media":19151,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236,264],"tags":[5903,5902],"stock_ticker":[],"class_list":["post-19150","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","category-health","tag-nasdaqqcor","tag-questcor-pharmaceuticals-inc-nasdaqqcor","entry"],"acf":[],"yoast_head":"\n